IBS Capital
North America, Massachusetts, United States, Boston
Description
IBS Capital is an advisory and investment management company that provides hedge fund investment services.
Investor Profile
IBS Capital has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 25% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Post Ipo Equity, Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series C (25%)
- Post Ipo Equity (25%)
- Series A (25%)
- Series Unknown (25%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Biopharma
- Neuroscience
- Pharmaceutical
- Commercial
- Manufacturing
- Mineral
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does IBS Capital frequently co-invest with?
Which angels does IBS Capital often collaborate with?
What are some of recent deals done by IBS Capital?
Find More Investors Like IBS Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides





